CircRERE调节miR-128-3p/WEE1轴促进人多发性骨髓瘤细胞系增殖、迁移和侵袭

doi:10.16352/j.issn.1001-6325.2024.02.0210

摘要/Abstract

摘要： 目的探究环状RNA RERE(circRERE)调节微小RNA(miR)-128-3p/丝氨酸/苏氨酸蛋白激酶(WEE1)轴对人多发性骨髓瘤(MM)细胞系增殖、迁移和侵袭的影响。方法体外培养从健康受试者外周血中分离的正常浆细胞(nPCs)和人MM细胞系(U266、RPMI-8226、NCI-H929、LP-1)。RT-qPCR检测circRERE、miR-128-3p表达;Western blot检测WEE1表达。转染RPMI-8226细胞后,将其分为对照组(control)(未进行转染)、sh-circRERE组、sh-NC组、miR-128-3p inhibitor组、inhibitor-NC组、sh-circRERE+inhibitor-NC组、sh-circRERE+miR-128-3p inhibitor组,噻唑蓝(MTT)实验和5-乙炔基-2’脱氧尿嘧啶核苷(EdU)免疫荧光染色检测细胞增殖;划痕愈合实验、Transwell小室法检测细胞迁移、侵袭;双荧光素酶报告基因实验证实miR-128-3p与circRERE或WEE1的靶向作用关系。结果与nPCs比较,MM细胞(RPMI-8226、U266、NCI-H929、LP-1)中circRERE、WEE1表达增加,miR-128-3p表达减少(P＜0.05);与对照组比较,sh-circRERE组RPMI-8226细胞增殖率、EdU阳性细胞比例、划痕面积愈合率、侵袭数均减少(P＜0.05),miR-128-3p inhibitor组则相反(P＜0.05);miR-128-3p inhibitor降低了sh-circRERE对RPMI-8226细胞增殖、迁移、侵袭的影响(P＜0.05)。双荧光素酶实验显示circRERE/miR-128-3p、miR-128-3p/WEE1存在靶向作用关系。结论 CircRERE能够促进RPMI-8226细胞增殖、迁移和侵袭,可能通过对miR-128-3p发挥海绵效应以增加WEE1表达而实现。

关键词: circRERE, miR-128-3p/WEE1轴, 多发性骨髓瘤细胞, 增殖, 迁移

Abstract: Objective To investigate the impacts of circular RNA RERE (circRERE) on proliferation, migration and invasion of human multiple myeloma (MM) cell lines by regulating microRNA (miR)-128-3p/serine/threonine protein kinase (WEE1) axis. Methods Normal plasma cells (nPCs) isolated from peripheral blood of healthy subjects and human MM cell lines(U266, RPMI-8226, NCI-H929, LP-1) were cultured. The expressions of circRERE and miR-128-3p were detected by RT-qPCR. The expression of WEE1 was detected by Western blot. After transfection, RPMI-8226 cells were divided into control group (without transfection), sh-circRERE group, sh-NC group, miR-128-3p inhibitor group, inhibitor-NC group, sh-circRERE+inhibitor-NC group and sh-circRERE+miR-128-3p inhibitor group. MTT assay and 5-ethynyl-2'-deoxyuridine (EdU) immunofluorescence staining microscopy were used to detect the proliferation. Migration and invasion were examined by scratch healing experiment as well as Transwell chamber assay. The targeting relationship between miR-128-3p and circRERE or WEE1 was verified though dual-luciferase reporter gene assay. Results Compared with nPCs, the expressions of circRERE and WEE1 in MM cells (RPMI-8226, U266, NCI-H929, LP-1) were increased, and the expression of miR-128-3p was decreased (P＜0.05). Compared with the control group, the proliferation rate, proportion of EdU positive cells, the healing rate of the scratch trauma and the number of invasion of the RPMI-8226 cells in sh-circRERE group were decreased(P＜0.05). However,miR-128-3p inhibitor group showed an opposite result and the difference was statistically significant (P＜0.05). miR-128-3p inhibitor significantly inhibited the effects of sh-circRERE on the proliferation, migration and invasion of RPMI-8226 cells (P＜0.05). Dual luciferase reporter gene experiments showed that circRERE/miR-128-3p and miR-128-3p/WEE1 had a targeting relationship. Conclusions CircRERE may promote proliferation, migration and invasion of RPMI-8226 cells, potentially with a mechanism of regulating miR-128-3p/WEE1 axis.

Key words: circRERE, miR-128-3p/WEE1 axis, multiple myeloma cells, proliferation, migration

中图分类号:

R733.3

方媛, 李轶, 王玮. CircRERE调节miR-128-3p/WEE1轴促进人多发性骨髓瘤细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2024, 44(2): 210-218.

FANG Yuan, LI Yi, WANG Wei. CircRERE promotes proliferation, migration and invasion of human multiple myeloma cell lines by regulating miR-128-3p/WEE1 axis[J]. Basic & Clinical Medicine, 2024, 44(2): 210-218.

参考文献

[1]Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: a review[J]. JAMA, 2022, 327: 464-477.
[2]张永梅,张志敏,周洁,等. LncRNA CBR3-AS1在多发性骨髓瘤中的表达及临床意义[J].基础医学与临床,2023,43:948-952.
[3]Fang W, Mu J, Yang Y, et al. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p[J]. J Bone Oncol, 2021, 30: 100381. doi: 10.1016/j.jbo.2021.100381
[4]Zhou F, Wang D, Wei W, et al. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma[J]. BMC Cancer, 2020, 20: 40. doi: 10.1186/s12885-020-6515-2.
[5]Liu Q, Ran R, Song M, et al. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2[J]. Cell Biol Toxicol, 2022, 38: 979-993.
[6]Ghelli Luserna di Rorà A, Cerchione C, Martinelli G, et al. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target[J]. J Hematol Oncol, 2020, 13: 126-142.
[7]Ling Z, Zhang J, Liu Q. Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis[J]. Bioengineered, 2022, 13: 6012-6023.
[8]Jakobsen T, Dahl M, Dimopoulos K, et al. Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells[J]. Cancers (Basel), 2021, 13: 365-383.
[9]Chen D, Yang X, Liu M, et al. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma[J]. Cancer Gene Ther, 2021, 28: 1256-1268.
[10]杨芒庄,杨旭东,王晓龙. Circ-MALAT1靶向miR-101抑制膀胱癌细胞系SW780侵袭和迁移[J]. 基础医学与临床,2022,42:472-478.
[11]Feng Y, Zhang L, Wu J, et al. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway[J]. J Exp Clin Cancer Res, 2019, 38: 54-70.
[12]Wang Y, Lin Q, Song C, et al. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis[J]. Cell Cycle, 2020, 19:3289-3302.
[13]Gorecki L, Andrs M, Korabecny J. Clinical candidates targeting the ATR-CHK1-WEE1 axis in cancer[J]. Cancers (Basel), 2021, 13: 795-816.
[14]华科雷,任莹坤,霍明科,等. miR-128-3p在胃癌组织中的表达及其对胃癌细胞迁移和侵袭能力的影响[J]. 中华普通外科杂志,2022,37:279-283.

[1]	郭艳芳, 耿超, 解相宏, 陈恩惠, 郭泽宇, 张明龙, 刘晓军. Sestrin1参与调控小鼠肝脏细胞糖异生[J]. 基础医学与临床, 2024, 44(2): 141-146.
[2]	廖镇城, 杨思懿, 吴平安. 提高m⁶A去甲基化酶FTO表达抑制鼻咽癌细胞增殖[J]. 基础医学与临床, 2024, 44(1): 57-62.
[3]	李江丽, 孙静, 唐一君, 郭君兰, 陈博, 郭胜男. Circ-DDX5靶向miR-3940抑制人乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2024, 44(1): 1-7.
[4]	苏拾香, 王语阳, 覃宗帅, 黄桂香, 徐键, 岑兰英, 覃月秋. miR-142-3p通过调控Hmgb1抑制雨蛙素诱导的大鼠胰腺外分泌细胞系AR42J凋亡[J]. 基础医学与临床, 2024, 44(1): 23-30.
[5]	潘闪, 林铿强, 陈树兴. 培美曲塞抑制人肺腺癌细胞系A549增殖[J]. 基础医学与临床, 2023, 43(9): 1359-1363.
[6]	朱锋, 钟粤, 邓义江, 刘文值, 边疆. 右美托咪定通过上调PPAR-γ改善神经病理性疼痛模型大鼠的痛觉敏化[J]. 基础医学与临床, 2023, 43(9): 1369-1374.
[7]	梁辉勇, 韦秋慧, 丁亚, 彭小青, 姚静, 苏齐鉴. 虫草素抑制TNF-α诱导的人角质形成细胞系HaCaT增殖[J]. 基础医学与临床, 2023, 43(9): 1390-1393.
[8]	杨婷婷, 黄洁, 郭建新, 韩健. DEPDC1在子宫内膜癌中表达上调[J]. 基础医学与临床, 2023, 43(9): 1399-1407.
[9]	黄洁, 李润博, 郭建新, 韩健. DDX5和DDX17在卵巢癌组织中的表达及对人卵巢癌细胞系SKOV3增殖和耐药的影响[J]. 基础医学与临床, 2023, 43(8): 1247-1253.
[10]	张培波, 李义. 沙棘总黄酮抑制膀胱癌细胞系T24增殖[J]. 基础医学与临床, 2023, 43(7): 1122-1126.
[11]	唐一君, 王文龙, 李江丽, 杨欢, 孙静. LncRNA RP11-686D22.10与乳腺癌患者生存期相关并影响乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43(7): 1023-1029.
[12]	金晓霞, 陆晓云, 刘玉山, 梁李娜. SIRT2在膀胱尿路上皮癌中的表达、临床意义及其对癌细胞增殖、侵袭和迁移的影响[J]. 基础医学与临床, 2023, 43(7): 1090-1096.
[13]	曾燕坤, 洪小颖, 陈清林. 下调BECN1抑制人白血病细胞系THP-1增殖、侵袭和迁移[J]. 基础医学与临床, 2023, 43(7): 1104-1109.
[14]	苏靓誉, 张振西, 杜文静. TPX2的表达对胰腺癌预后的影响[J]. 基础医学与临床, 2023, 43(6): 875-881.
[15]	张海灵, 杨玉, 周倩倩, 汪远金, 王婷. 微囊藻毒素-LR处理的中性粒细胞NETs促进结直肠癌细胞迁移[J]. 基础医学与临床, 2023, 43(6): 967-973.